Home Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay
Article
Licensed
Unlicensed Requires Authentication

Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay

  • Ricardo Gonzalo , Cristofol Vives-Bauza , Antonio L. Andreu and Elena García-Arumí
Published/Copyright: June 1, 2005

Abstract

The malondialdehyde-thiobarbituric acid assay is widely used to study lipid peroxidation. Among the various methods used to perform the assay, the most widely accepted is the quantification of malondialdehyde using the thiobarbituric acid reaction, followed by reversed-phase chromatography. However, unacceptable results may be obtained as malondialdehyde can be produced in vitro. To study the conditions that inhibit in vitro lipid peroxidation, malondialdehyde levels were measured in cultured cells using different concentrations of butylated hydroxytoluene, EDTA or a combination of both. Butylated hydroxytoluene alone inhibits in vitro lipid peroxidation effectively. EDTA reduces artificially produced malondialdehyde, but not totally. Finally, the combination of EDTA and butylated hydroxytoluene does not improve the results obtained using butylated hydroxytoluene alone. The conclusion is that in the malondialdehyde-thiobarbituric acid assay it is necessary to add an inhibitor of the in vitro lipid peroxidation and assay the necessary concentration depending on the specimen used.


Corresponding author: Elena García-Arumí, PhD, Centre d’Investigacions en Bioquímica i Biologia Molecular, Hospital Vall d’Hebron, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain. Phone: (+34)934894054, Fax: (+34)934894040, E-mail:

References

1 Pryor WA, Stanley JP, Blair E. Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 1976; 11:370–9.10.1007/BF02532843Search in Google Scholar

2 Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989; 70:737–57.Search in Google Scholar

3 Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15:212–6.10.1016/0006-2944(76)90049-1Search in Google Scholar

4 Yu LW, Latriano L, Duncan S, Hartwick RA, Witz G. High-performance liquid chromatography analysis of the thiobarbituric acid adducts of malonaldehyde and trans,trans-muconaldehyde. Anal Biochem 1986; 156:326–33.10.1016/0003-2697(86)90261-7Search in Google Scholar

5 Sinhuber RO, Yu TC. Characterization of the red pigment formed in the 2-thiobarbituric acid determination of oxidative rancidity. Food Res 1958; 23:626–34.10.1111/j.1365-2621.1958.tb17614.xSearch in Google Scholar

6 Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. Biochem J 1971; 123:823–8.10.1042/bj1230823Search in Google Scholar

7 Bird RP, Draper HH. Comparative studies on different methods of malonaldehyde determination. Methods Enzymol 1984; 105:299–305.10.1016/S0076-6879(84)05038-2Search in Google Scholar

8 Gilbert HS, Stump DD, Roth EF Jr. A method to correct for errors caused by generation of interfering compounds during erythrocyte lipid peroxidation. Anal Biochem 1984; 137:282–6.10.1016/0003-2697(84)90086-1Search in Google Scholar

9 Bird RP, Hung SS, Hadley M, Draper HH. Determination of malonaldehyde in biological materials by high-pressure liquid chromatography. Anal Biochem 1983; 128:240–4.10.1016/0003-2697(83)90371-8Search in Google Scholar

10 Jordan RA, Schenkman JB. Relationship between malondialdehyde production and arachidonate consumption during NADPH-supported microsomal lipid peroxidation. Biochem Pharmacol 1982; 31:393–400.Search in Google Scholar

11 Yagi K. Assay for serum lipid peroxide level and its clinical significance. In Yagi K, editor. Lipid peroxides in biology and medicine. New York: Academic Press, 1982:223–42.10.1016/B978-0-12-768050-7.50020-2Search in Google Scholar

12 Young LS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28:504–8.10.1177/000456329102800514Search in Google Scholar PubMed

13 Fraga CG, Leibovitz BE, Tappel AL. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 1988; 4:155–61.10.1016/0891-5849(88)90023-8Search in Google Scholar

14 Rice-Evans CA, Diplock AT, Symons MC. Techniques in free radical research. In: Burdon RH, van Knippenberg PH, editors. Laboratorytechniques in biochemistry and molecular biology. Amsterdam: Elsevier, 1991:125–84.Search in Google Scholar

15 Knight JA, Voorhees RP, Martin L. The effect of metal chelators on lipid peroxidation in stored erythrocytes. Ann Clin Lab Sci 1992; 22:207–13.Search in Google Scholar

16 Petrusca JM, Wong SH, Sunderman Jr FW, Mossman BT. Detection of lipid peroxidation in lung and in bronchoalveolar lavage cells and fluid. Free Radic Biol Med 1990; 9:51–8.10.1016/0891-5849(90)90049-OSearch in Google Scholar

17 Lepage G, Munoz G, Champagne J, Roy CC. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem 1991; 197:277–83.10.1016/0003-2697(91)90392-7Search in Google Scholar

18 Nielsen F, Borg Mikkelsen B, Bo Nielsen J, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of lifestyle factors. Clin Chem 1997; 43:1209–17.10.1093/clinchem/43.7.1209Search in Google Scholar

19 Li XY, Chow CK. An improved method for the measurement of malondialdehyde in biological samples. Lipids 1994; 29:73–5.10.1007/BF02537094Search in Google Scholar

20 Pang CY, Lee HC, Wei YH. Enhanced oxidative damage in human cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes. Diabetes Res Clin Pract 2001; 54:S45–6.10.1016/S0168-8227(01)00335-7Search in Google Scholar

21 Volpi N, Tarugi P. Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma. J Chromatogr B Biomed Sci Appl 1998; 713:433–7.10.1016/S0378-4347(98)00195-9Search in Google Scholar

22 Suttnar J, Masova L, Dyr JE. Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography. J Chromatogr B Biomed Sci 2001; 751:193–7.10.1016/S0378-4347(00)00453-9Search in Google Scholar

23 Richard MJ, Guiraud P, Meo J, Favier A. High-performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent. J Chromatogr Biomed Appl 1992; 577:9–18.10.1016/0378-4347(92)80593-FSearch in Google Scholar

24 Agarwal R, Chase SD. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B Biomed Sci 2002; 775:121–6.10.1016/S1570-0232(02)00273-8Search in Google Scholar

25 Fukunaga K, Suzuki T, Takama K. Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples. J Chromatogr 1993; 621:77–81.10.1016/0378-4347(93)80078-ISearch in Google Scholar

26 Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996; 20:251–6.10.1016/0891-5849(95)02043-8Search in Google Scholar

27 Lambert CR, Black HS, Truscott TG. Reactivity of butylated hydroxytoluene. Free Radic Biol Med 1996; 21:395–400.10.1016/0891-5849(96)00050-0Search in Google Scholar

Received: 2004-2-2
Accepted: 2004-7-16
Published Online: 2005-6-1
Published in Print: 2004-8-1

© Walter de Gruyter

Articles in the same Issue

  1. Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis
  2. Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with age and disease activity
  3. A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer
  4. N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias
  5. Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay
  6. Oxidative stress: potential of distinct peroxide determination systems
  7. Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance
  8. Guidelines for blood smear preparation and staining procedure for setting up an external quality assessment scheme for blood smear interpretation. Part I: control material
  9. Measurement of serum and plasma osmolality in healthy young humans – influence of time and storage conditions
  10. High in-hospital mortality of intensive care patients with nucleated red blood cells in blood
  11. Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations
  12. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
  13. Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared
  14. Antioxidant capacity of the human pericardial fluid: does gender have a role?
  15. Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx® and dry chemistry enzyme immunoassay on the Vitros 950
  16. Multicenter analytical performance evaluation of the Elecsys® proBNP assay
  17. Analytical evaluation and reference values of serum amyloid-A on the BN ProSpec
  18. Reference values of soluble interleukin-2 receptor on the IMMULITE
  19. Analysis of cystatin C, creatinine, albumin, lipids and lipoprotein concentrations in serum and acidified citrate plasma (Stabilyte™) tubes compared
  20. Analysis of γ-globulins consisting of hepatitis C-associated cryoglobulins in the blood
  21. Serum total glutathione-S-transferase in stroke, a preliminary report
  22. Santorini Biologie Prospective Conference 2004 “From Human Genetic Variations to Prediction of Risks and Responses to the Environment”, Santorini, Greece, September 30–October 4, 2004
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.146/html
Scroll to top button